Compare Cenovus Energy Inc (CVE) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cenovus Energy Inc vs Zimmer Biomet Holdings Inc — how do they compare? Cenovus Energy Inc trades at $31.5 (market cap $57.90B), while Zimmer Biomet Holdings Inc trades at $89.07 (market cap $16.95B). The key difference: Cenovus Energy Inc is far larger — about 3.4× Zimmer Biomet Holdings Inc's market cap, and Cenovus Energy Inc pays the higher dividend (1.97%). Which is the better fit depends on your goals — on Pluang, investors hold Cenovus Energy Inc for 46 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| CVE | ZBH | |
|---|---|---|
Market Cap | $57.90B | $16.95B |
Volume | 7,863,588 | 2,505,240 |
Sector | Energy | Health |
52-Week High | $33.92 | $103.98 |
52-Week Low | $15.85 | $79.58 |
Typical Hold Time | 46 Days | 89 Days |
Enterprise Value | $63.84B | $24.02B |
Dividend Yield | 1.97% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cenovus Energy (CVE) trades at $31.53, up 2.94% with a bullish technical signal and strong institutional support. The stock shows solid fundamentals with a P/E of 12.43, net income margin of 11.48%, and consistent earnings beats in recent quarters. Recent analyst upgrades and positive media coverage highlight the company's attractive valuation and growth prospects in the energy sector.
Outlook remains positive with projected 2026 revenue of $58.0B and net income of $6.7B, though investors should monitor oil price volatility and execution risks. Analyst consensus leans bullish with 11 buy ratings versus 1 sell, while technical indicators suggest potential resistance near $32.
Zimmer Biomet (ZBH) trades at $88.49, down 1.33% today, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.07 surpassing the $2.01 estimate. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated to 9.48%. A quarterly dividend of $0.24 was declared, payable in October 2026. Analyst consensus price target is $103.11, implying potential upside from current levels.
The outlook is mixed: solid fundamentals and earnings momentum support long-term value, but technical weakness and elevated debt levels pose near-term risks. Investment appeal hinges on execution of commercial transformation and robotics adoption offsetting competitive pressures. Key risks include margin compression and macroeconomic sensitivity affecting procedure volumes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cenovus Energy Inc
Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
